WHO identified Visceral Leishmaniasis (VL) as a Category I disease (emerging and uncontrolled) and the support to the Elimination control programs in India, Nepal and Bangladesh were intensified in 2005. One of the key approaches that allows accelerated efforts towards the elimination process is by focusing on availability, affordability and accessibility of medicines used to treat VL. This presentation by Ms. Aishwarya Kulkarni, who has completed her BPharm, focuses on the evolution of the medicines for VL, their prices and some of the current issues in this regard.

Speaker

Aishwarya

k

Affiliation

IPH Intern

Date

26-July-2018

Time

3.00 pm – 4.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Admissions open for 2019!

The eSWaRM course will enable health professionals to write scientific research articles that can be published and to equip them with skills to cite and manage references/ bibliography while writing using a reference management tool such as Mendeley.

You have Successfully Subscribed!